tiprankstipranks
Advertisement
Advertisement

Skanska Wins USD 165 Million Texas A&M Biology Facility Contract

Story Highlights
  • Skanska won a USD 165 million contract to build a new biology teaching and research facility at Texas A&M in College Station.
  • The 17,200-square-meter, state-of-the-art life sciences building will replace outdated facilities, with construction from 2027 to 2029 and bolster Skanska’s U.S. order book.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Skanska Wins USD 165 Million Texas A&M Biology Facility Contract

Claim 55% Off TipRanks

Skanska AB ( ($SE:SKA.B) ) has shared an update.

Skanska has secured a USD 165 million (about SEK 1.5 billion) contract from The Texas A&M University System to build a new Biology Teaching & Research facility in College Station, Texas, reinforcing its presence in the U.S. higher-education construction market. The 17,200-square-meter project, which will replace outdated biology buildings with state-of-the-art labs, active-learning classrooms and collaboration spaces, is slated to start in spring 2027 and complete in spring 2029, adding to Skanska’s U.S. order bookings for the first quarter of 2026 and supporting its focus on complex, research-driven campus projects.

The most recent analyst rating on ($SE:SKA.B) stock is a Buy with a SEK309.00 price target. To see the full list of analyst forecasts on Skanska AB stock, see the SE:SKA.B Stock Forecast page.

More about Skanska AB

Skanska is one of the world’s largest construction and project development companies, with 2025 revenue of SEK 179 billion and operations across selected markets in the Nordics, Europe and the USA. The group leverages the expertise of about 25,900 employees to deliver innovative, sustainable buildings and infrastructure that shape how people live, work and connect.

Average Trading Volume: 799,692

Technical Sentiment Signal: Buy

Current Market Cap: SEK101B

For an in-depth examination of SKA.B stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1